Global /India /Healthcare /Drug Manufacturers - General /ANUHPHR

Anuh Pharma Ltd.

ANUHPHR

• NSE: ANUHPHR • Delayed

81.20INR -1%

0.8600 USD

As of 20 June 2026, Anuh Pharma Ltd. has a market cap of $87.06M USD, ranking #26541 globally and #1645 in India. It ranks #2378 in the Healthcare sector, and #856 in the Drug Manufacturers - General industry.

Global Rank

26541

Country Rank

1645

Sector Rank

2378

Industry Rank

856

Key Stats

Market Cap

$87.06MUSD

8.22B INR

Enterprise Value

$85.67MUSD

8.09B INR

Revenue (TTM)

$81.33MUSD

7.68B INR

EBITDA (TTM)

$6.1MUSD

576.28M INR

Net Income (TTM)

$4.43MUSD

418.22M INR

EBITDA Margin

7.5%

Profit Margin

5.4%

PE Ratio

19.6

PS Ratio

1.1

PB Ratio

2.5

EV/EBITDA

13.9

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

295

Founded

1960

Website

anuhpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	1.6%	17%	12%	-9.2%	1.9%	-5.5%	-33%	-33%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	ANUHPHR Anuh Pharma Ltd Shs Dematerialised ISIN: INE489G01022 Shares Out.: Shares Outstanding: 100.224M¹ Shares Float: 27.576M² TV: TradingView: NSE: ANUHPHR SA: Stock Analysis: NSE: ANUHPHR YF: Yahoo Finance: ANUHPHR.NS GF: Google Finance: NSE: ANUHPHR BA: Barron's: ANUHPHR MS: Morningstar: XNSE: ANUHPHR	81.20 INR	TV: TradingView: NSE: ANUHPHR SA: Stock Analysis: NSE: ANUHPHR YF: Yahoo Finance: ANUHPHR.NS GF: Google Finance: NSE: ANUHPHR BA: Barron's: ANUHPHR MS: Morningstar: XNSE: ANUHPHR
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	506260 (ANUHPHR) Anuh Pharma Ltd Shs Dematerialised ISIN: INE489G01022 TV: TradingView: BSE: ANUHPHR SA: Stock Analysis: BOM: 506260 YF: Yahoo Finance: 506260.BO GF: Google Finance: BOM: 506260 BA: Barron's: 506260 MS: Morningstar: XBOM: 506260	82.10 INR	TV: TradingView: BSE: ANUHPHR SA: Stock Analysis: BOM: 506260 YF: Yahoo Finance: 506260.BO GF: Google Finance: BOM: 506260 BA: Barron's: 506260 MS: Morningstar: XBOM: 506260

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anuh Pharma Ltd.

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 52K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 21K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 17K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 13K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 11K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 11K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 875K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 629K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 414K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 365K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 327K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 315K%	15.1	United States

chevron_leftBack